Finance

Lists
NV40:FRA
Cellectar Biosciences Inc
€0,25
0,00%
(0,00) 1D
24 Jun., 08:08:19 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NV40...
Mkt. cap
13,71 m
Volume
0,00
52-wk high
€0,25
52-wk low
€0,25
No. of employees
11
Mkt. cap
13,71 m
Volume
0,00
52-wk high
€0,25
52-wk low
€0,25
No. of employees
11
News stories
From web sources and news partners
About Cellectar Biosciences Inc
CEO-
Employees11
Founded1996
HeadquartersFlorham Park, New Jersey, Verenigde State van Amerika
Sector-
Websitecellectar.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2,52 m
3,16 m
3,01 m
4,56 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,33 m
2,53 m
2,79 m
2,64 m
Operating expense
4,85 m
5,69 m
5,79 m
7,20 m
Total operating expenses
4,85 m
5,69 m
5,79 m
7,20 m
Operating income
-4,85 m
-5,69 m
-5,79 m
-7,20 m
Other non operating income
294,28 k
297,83 k
77,00 k
132,00 k
EBT including unusual items
-4,44 m
-5,30 m
-5,65 m
-6,93 m
EBT excluding unusual items
-4,44 m
-5,30 m
-5,65 m
-6,93 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-4,44 m
-5,30 m
-5,65 m
-6,93 m
Net profit margin
-
-
-
-
Earnings per share
-1,41
-0,53
-1,33
-0,57
Interest and investment income
112,54 k
97,58 k
63,00 k
133,36 k
Interest expense
-
-
-
-
Net interest expenses
112,54 k
97,58 k
63,00 k
133,36 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-4,80 m
-5,64 m
-5,74 m
-7,16 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme